Sugi Predict

Sugi Predict / Compounds / SCHEMBL1775710

SCHEMBL1775710

SCHEMBL1775710

Cc1ccc([C](c2ccc(C)cc2)c2ccc(C)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ CES2 O00748 3/20 0.58
▸ CES1 P23141 3/20 0.58
▸ LMNA P02545 2/20 0.58
▸ TDP1 Q9NUW8 3/20 0.57
▸ ACHE P22303 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ KMT2A Q03164 3/20 0.50
▸ PKM P14618 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ ATM Q13315 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NLRP1 Q9C000 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ NTSR1 P30989 1/20 0.50
▸ SRD5A2 P31213 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60996 0.88 CES2 (0.65) ALDH1A1CES2CES1LMNATDP1
SCHEMBL336773 0.88 CES2 (0.65) ALDH1A1CES2CES1LMNATDP1
SCHEMBL8470601 0.86 ALDH1A1 (0.68) ALDH1A1CES2CES1LMNATDP1
SCHEMBL4158833 0.82 ACHE (0.71) ALDH1A1CES2CES1ACHESMN1; SMN2
SCHEMBL17923686 0.79 ALDH1A1 (0.58) ALDH1A1CES2CES1LMNATDP1
P-Xylene SCHEMBL6272681 0.76 ACHE (0.80) ALDH1A1CES2CES1LMNATDP1
P-Xylene SCHEMBL28696945 0.76 ACHE (0.80) ALDH1A1CES2CES1LMNATDP1
P-Xylene SCHEMBL28442305 0.76 ACHE (0.80) ALDH1A1CES2CES1LMNATDP1
P-Xylene SCHEMBL9720651 0.76 ACHE (0.80) ALDH1A1CES2CES1LMNATDP1
P-Xylene SCHEMBL28540852 0.76 ACHE (0.80) ALDH1A1CES2CES1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779911-B2 Production of fatty olefin derivatives via olefin metathesis PROVIVI, INC. (US) 2023-10-10 — — US claimed
CN-115010839-B Amine-containing bisphenol tetradentate ligand fourth subgroup metal complex catalyst system and application thereof 吉林大学 2023-06-20 — — CN claimed
CN-115215748-A Production of aliphatic olefin derivatives by olefin metathesis 普罗维维公司 2022-10-21 — — CN claimed
US-20220032280-A1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS PROVIVI, INC. (US) 2022-02-03 — — US claimed
EP-3662996-A2 MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS Verbio Vereinigte BioEnergie AG (DE) 2020-06-10 — — EP claimed
CN-110603240-A Synthesis of pheromones and related substances via olefin metathesis 普罗维维公司 2019-12-20 — — CN claimed
US-10343153-B2 Metathesis catalysts and reactions using the catalysts XIMO AG (CH) 2019-07-09 — — US claimed
EP-3377465-A2 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS Provivi, Inc. (US) 2018-09-26 — — EP claimed
WO-2018150379-A2 SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS PROVIVI, INC. (US) 2018-08-23 — — WO claimed
EP-2623507-B1 MORPHOLINO NUCLEIC ACID DERIVATIVE NIPPON SHINYAKU CO LTD (JP) 2016-11-02 — — EP claimed
US-20130197220-A1 Morpholino Nucleic Acid Derivatives NIPPON SHINYAKU CO., LTD. (JP) 2013-08-01 — — US claimed
US-8299206-B2 Method of synthesis of morpholino oligomers AVI BIOPHARMA, INC. (US) 2012-10-30 — — US claimed
US-8076476-B2 Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits AVI BIOPHARMA, INC. (US) 2011-12-13 — — US claimed
EP-2207779-A1 METHOD OF SYNTHESIS OF MORPHOLINO OLIGOMERS Avi Biopharma, Inc. (US) 2010-07-21 — — EP claimed
WO-2009064471-A1 METHOD OF SYNTHESIS OF MORPHOLINO OLIGOMERS AVI BIOPHARMA, INC. (US) 2009-05-22 — — WO claimed
US-20090131632-A1 METHOD OF SYNTHESIS OF MORPHOLINO OLIGOMERS AVI BIOPHARMA, INC. (US) 2009-05-21 — — US claimed
US-20090131624-A1 SYNTHESIS OF MORPHOLINO OLIGOMERS USING DOUBLY PROTECTED GUANINE MORPHOLINO SUBUNITS AVI BIOPHARMA, INC. (US) 2009-05-21 — — US claimed
EP-0536710-B1 Amino acid derivatives for peptide synthesis BACHEM FEINCHEMIKALIEN AG (CH) 1996-05-08 — — EP claimed
US-5455363-A Having trityl as amide-protecting group for asparagine and glutamine; reduced side reaction GOSTELI JACQUES (CH) 1995-10-03 — — US claimed
EP-0536710-A1 Amino acid derivatives for peptide synthesis BACHEM FEINCHEMIKALIEN AG (CH) 1993-04-14 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10343153-B2 Metathesis catalysts and reactions using the catalysts MSMO1, SQLE, MOGAT2 ALDH1A1 994/4885CES2 699/4885CES1 318/4885
US-20130197220-A1 Morpholino Nucleic Acid Derivatives MORF4L1, METTL16, METTL3 ALDH1A1 2942/4885CES2 4444/4885CES1 3415/4885
US-11779911-B2 Production of fatty olefin derivatives via olefin metathesis SREBF1, F2, SREBF2 ALDH1A1 1913/4885CES2 2005/4885CES1 599/4885
US-20220032280-A1 PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS SREBF1, F2, SREBF2 ALDH1A1 1913/4885CES2 2005/4885CES1 599/4885
US-20090131624-A1 SYNTHESIS OF MORPHOLINO OLIGOMERS USING DOUBLY PROTECTED GUANINE MORPHOLINO SUBUNITS RNMT, O60361, PAM ALDH1A1 4729/4885CES2 4827/4885CES1 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.